Early detection and diagnosis of diseases can save lives and improve the economy of the country. Diagnostic companies have contributed to the growth of the economy by enhancing medicine and improving health care costs. These businesses also improve patient outcomes and ease the complex works of medical practitioners.
One of the trusted diagnostic companies in the United States is Nanosphere, Inc. Through the company’s patented technologies, they are able to help doctors and medical practitioners diagnose and detect bacteria and viruses that are responsible for deadly infections and costly diseases. The complex and highly advanced solutions offered by the company are on point with its diagnosis. Its test menu targets the detection of infections of the gastrointestinal tract, respiratory tract and the bloodstream. For years, the experts in the company have perfected their Verigene System to remain accurate with its reading. Through this platform, they are able to help clinicians rapidly identify these deadly bacteria and viruses.
The Verigene System is capable of running multiple tests using just one sample. This would mean that clinicians need not draw more blood and do other sample collection as this platform allows genomic and protein testing in one go. This system uses several reagents and other disposable consumables to prepare the specimen. Its components include a microfluidics processor, target amplification, test cartridges and a touchscreen reader. It is then connected to the web, and allows its users to continuously monitor and remotely access results and reports. This diagnostic platform is strongly focused on the infectious disease diagnostic market.
Headquartered in Northbrook, Illinois, Nanosphere was created in 1999 by Dr. Robert Letsinger and Dr. Chad Mirkin. They developed their system at Northwestern University. In 2007, the business went public and today, continues to trade on the NASDAQ. It uses the ticker symbol NSPH to market its common shares.
No comments:
Post a Comment